TNFRSF11B and psoriatic arthritis: This might be explained by the stronger systemic inflammation, which is proved by the higher levels of interleukin-6, CD16+ proinflammatory monocytes, osteoprotegerin, high-sensitive C-reactive protein, and vascular endothelial growth factor in psoriatic arthritis compared to psoriasis alone [29].